Literature DB >> 27559077

Temporal Lobe Volume Decrements in Psychosis Spectrum Youths.

David R Roalf1, Megan Quarmley1, Monica E Calkins1, Theodore D Satterthwaite1, Kosha Ruparel1, Mark A Elliott2, Tyler M Moore1, Ruben C Gur1,2, Raquel E Gur1,2, Paul J Moberg1,3, Bruce I Turetsky1,3.   

Abstract

Structural brain abnormalities have been amply demonstrated in schizophrenia. These include volume decrements in the perirhinal/entorhinal regions of the ventromedial temporal lobe, which comprise the primary olfactory cortex. Olfactory impairments, which are a hallmark of schizophrenia, precede the onset of illness, distinguish adolescents experiencing prodromal symptoms from healthy youths, and may predict the transition from the prodrome to frank psychosis. We therefore examined temporal lobe regional volumes in a large adolescent sample to determine if structural deficits in ventromedial temporal lobe areas were associated, not only with schizophrenia, but also with a heightened risk for psychosis. Seven temporal lobe regional volumes (amygdala [AM], hippocampus, inferior temporal gyrus, parahippocampal gyrus, superior temporal gyrus, temporal pole, and entorhinal cortex [EC]) were measured in 386 psychosis spectrum adolescents, 521 adolescents with other types of psychopathology, and 359 healthy adolescents from the Philadelphia Neurodevelopment Cohort. Total intracranial and left EC volumes, which were both smallest among the psychosis spectrum, were the only measures that distinguished all 3 groups. Left AM was also smaller in psychosis spectrum compared with healthy subjects. EC volume decrement was strongly correlated with impaired cognition and less robustly associated with heightened negative/disorganized symptoms. AM volume decrement correlated with positive symptoms (persecution/special abilities). Temporal lobe volumes classified psychosis spectrum youths with very high specificity but relatively low sensitivity. These MRI measures may therefore serve as important confirmatory biomarkers denoting a worrisome preclinical trajectory among at-risk youths, and the specific pattern of deficits may predict specific symptom profiles.
© The Author 2016. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  MRI; negative symptoms; neurodevelopment; olfaction; psychosis risk

Mesh:

Year:  2017        PMID: 27559077      PMCID: PMC5463880          DOI: 10.1093/schbul/sbw112

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  66 in total

1.  Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders.

Authors:  Yoonho Chung; Aron Jacobson; George He; Theo G M van Erp; Sarah McEwen; Jean Addington; Carrie E Bearden; Kristin Cadenhead; Barbara Cornblatt; Daniel H Mathalon; Thomas McGlashan; Diana Perkins; Larry J Seidman; Ming Tsuang; Elaine Walker; Scott W Woods; Robert Heinssen; Tyrone D Cannon
Journal:  Mol Neuropsychiatry       Date:  2015-05-01

2.  Structural Brain Abnormalities in Youth With Psychosis Spectrum Symptoms.

Authors:  Theodore D Satterthwaite; Daniel H Wolf; Monica E Calkins; Simon N Vandekar; Guray Erus; Kosha Ruparel; David R Roalf; Kristin A Linn; Mark A Elliott; Tyler M Moore; Hakon Hakonarson; Russell T Shinohara; Christos Davatzikos; Ruben C Gur; Raquel E Gur
Journal:  JAMA Psychiatry       Date:  2016-05-01       Impact factor: 21.596

3.  The development of the human amygdala during early embryonic life.

Authors:  T Humphrey
Journal:  J Comp Neurol       Date:  1968-01       Impact factor: 3.215

4.  From perception to functional outcome in schizophrenia: modeling the role of ability and motivation.

Authors:  Michael F Green; Gerhard Hellemann; William P Horan; Junghee Lee; Jonathan K Wynn
Journal:  Arch Gen Psychiatry       Date:  2012-12

5.  The psychosis spectrum in a young U.S. community sample: findings from the Philadelphia Neurodevelopmental Cohort.

Authors:  Monica E Calkins; Tyler M Moore; Kathleen R Merikangas; Marcy Burstein; Theodore D Satterthwaite; Warren B Bilker; Kosha Ruparel; Rosetta Chiavacci; Daniel H Wolf; Frank Mentch; Haijun Qiu; John J Connolly; Patrick A Sleiman; Hakon Hakonarson; Ruben C Gur; Raquel E Gur
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

6.  Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease.

Authors:  T J Crow; J Ball; S R Bloom; R Brown; C J Bruton; N Colter; C D Frith; E C Johnstone; D G Owens; G W Roberts
Journal:  Arch Gen Psychiatry       Date:  1989-12

Review 7.  Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures.

Authors:  Bruce I Turetsky; Monica E Calkins; Gregory A Light; Ann Olincy; Allen D Radant; Neal R Swerdlow
Journal:  Schizophr Bull       Date:  2006-11-29       Impact factor: 9.306

8.  Impact of avolition and cognitive impairment on functional outcome in first-episode schizophrenia-spectrum disorder: a prospective one-year follow-up study.

Authors:  Wing Chung Chang; Christy Lai Ming Hui; Sherry Kit Wa Chan; Edwin Ho Ming Lee; Eric Yu Hai Chen
Journal:  Schizophr Res       Date:  2016-01-09       Impact factor: 4.939

9.  The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder.

Authors:  Patrick D McGorry; Alison R Yung; Lisa J Phillips
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

10.  Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivo.

Authors:  Jessica M Posimo; Amanda M Titler; Hailey J H Choi; Ajay S Unnithan; Rehana K Leak
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more
  13 in total

1.  Persistence of psychosis spectrum symptoms in the Philadelphia Neurodevelopmental Cohort: a prospective two-year follow-up.

Authors:  Monica E Calkins; Tyler M Moore; Theodore D Satterthwaite; Daniel H Wolf; Bruce I Turetsky; David R Roalf; Kathleen R Merikangas; Kosha Ruparel; Christian G Kohler; Ruben C Gur; Raquel E Gur
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

2.  Facial emotion perception abilities are related to grey matter volume in the culmen of cerebellum anterior lobe in drug-naïve patients with first-episode schizophrenia.

Authors:  Xiaoxin Zhao; Jingjing Yao; Yiding Lv; Xinyue Zhang; Chongyang Han; Lijun Chen; Fangfang Ren; Qun Zhou; Zhuma Jin; Yuan Li; Yasong Du; Yuxiu Sui
Journal:  Brain Imaging Behav       Date:  2022-06-25       Impact factor: 3.224

3.  Thalamic Nuclei Volumes in Psychotic Disorders and in Youths With Psychosis Spectrum Symptoms.

Authors:  Anna S Huang; Baxter P Rogers; Julia M Sheffield; Maria E Jalbrzikowski; Alan Anticevic; Jennifer Urbano Blackford; Stephan Heckers; Neil D Woodward
Journal:  Am J Psychiatry       Date:  2020-09-11       Impact factor: 18.112

4.  Structural anomalies of the peripheral olfactory system in psychosis high-risk subjects.

Authors:  Bruce I Turetsky; Paul J Moberg; Megan Quarmley; Erich Dress; Monica E Calkins; Kosha Ruparel; Karthik Prabhakaran; Raquel E Gur; David R Roalf
Journal:  Schizophr Res       Date:  2017-09-30       Impact factor: 4.939

5.  Neuroanatomical Abnormalities in Violent Individuals with and without a Diagnosis of Schizophrenia.

Authors:  Victor A Del Bene; John J Foxe; Lars A Ross; Menahem I Krakowski; Pal Czobor; Pierfilippo De Sanctis
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

6.  State-Dependent Functional Dysconnectivity in Youth With Psychosis Spectrum Symptoms.

Authors:  Eva Mennigen; Dietsje D Jolles; Catherine E Hegarty; Mohan Gupta; Maria Jalbrzikowski; Loes M Olde Loohuis; Roel A Ophoff; Katherine H Karlsgodt; Carrie E Bearden
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

Review 7.  Psychosis Risk and Development: What Do We Know From Population-Based Studies?

Authors:  Eva Mennigen; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2019-12-20       Impact factor: 13.382

8.  A Systematic Review of Cognition-Brain Morphology Relationships on the Schizophrenia-Bipolar Disorder Spectrum.

Authors:  James A Karantonis; Sean P Carruthers; Susan L Rossell; Christos Pantelis; Matthew Hughes; Cassandra Wannan; Vanessa Cropley; Tamsyn E Van Rheenen
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 7.348

9.  mGluR5 receptor availability is associated with lower levels of negative symptoms and better cognition in male patients with chronic schizophrenia.

Authors:  Cláudia Régio Brambilla; Tanja Veselinović; Ravichandran Rajkumar; Jörg Mauler; Linda Orth; Andrej Ruch; Shukti Ramkiran; Karsten Heekeren; Wolfram Kawohl; Christine Wyss; Elena Rota Kops; Jürgen Scheins; Lutz Tellmann; Frank Boers; Bernd Neumaier; Johannes Ermert; Hans Herzog; Karl-Josef Langen; N Jon Shah; Christoph Lerche; Irene Neuner
Journal:  Hum Brain Mapp       Date:  2020-03-09       Impact factor: 5.038

10.  MRI Indices of Cortical Development in Young People With Psychotic Experiences: Influence of Genetic Risk and Persistence of Symptoms.

Authors:  Leon Fonville; Mark Drakesmith; Stanley Zammit; Glyn Lewis; Derek K Jones; Anthony S David
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.